Resource Guide: FDA warning Reglan Tardive Dyskinesia

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Detailed topic guide

FDA warning Reglan Tardive Dyskinesia: A Detailed Overview — detailed background and analysis.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.